Target intelligence / Profile preview

DNA-dependent protein kinase catalytic subunit; Ataxia telangiectasia mutated; ATM and Rad3-related kinase (DNA-PKcs; ATM; ATR)

Target
DNA-PKcs; ATM; ATR
Molecular classification
Enzyme, Protein kinase, Phosphatidylinositol 3-kinase-related kinase family (PIKKs)
01

Overview

DNA-PKcs, ATM, and ATR are central kinases in the DNA damage response, responsible for detecting DNA lesions and orchestrating repair through phosphorylation of a broad network of substrates. DNA-PKcs primarily mediates nonhomologous end joining of double-strand breaks, ATM is crucial for the homologous recombination pathway and cell cycle checkpoint activation after ionizing radiation, while ATR responds to a wide spectrum of DNA damage including replication stress. Dysfunction or inhibition of these kinases contributes to cancer susceptibility, neurodevelopmental disorders, and can be exploited therapeutically to sensitize cancer cells to cytotoxic therapies[2][3][4][5][7].

Other names
DNA-dependent protein kinase, catalytic subunitPRKDCXRCC7Ataxia telangiectasia mutatedS-T kinase ATMATM- and Rad3-relatedS-T kinase ATR
02

Mechanism of action

Inhibition of kinase activity leads to impaired DNA repair, sensitizing cancer cells to chemotherapy and radiotherapy[1][7]. Synthetic lethality: Tumor cells deficient in ATM are reliant on DNA-PKcs; inhibition leads to cell death[5]. Checkpoint abrogation: Inhibiting ATM or ATR can prevent cell cycle arrest in response to DNA damage.

03

Biological functions

DNA damage response (DDR)DNA repair (ATM: homologous recombination; DNA-PKcs: nonhomologous end joining (NHEJ); ATR: response to replication stress)Cell cycle checkpoint control (G1, S, G2/M)Apoptosis regulationGenomic stability maintenance
04

Disease associations

CancerNeurodegenerative diseaseNeurodevelopmental disorders
05

Safety considerations

Increased toxicity to normal (particularly proliferating) tissuesPotential neurotoxicity (given roles in neurodevelopment)[2]Genomic instability and secondary malignancies[7]
06

Interacting drugs

M3814

7 more in the full profile.

07

Biomarkers

Expression/activity levels of DNA-PKcs, ATM, and ATR (e.g., elevated DNA-PKcs in various cancers)[5]Phosphorylation status of DDR substrates (e.g., p53, Chk1, Chk2)[1][3]Genomic instability markers

Beyond the preview

Go deeper on DNA-dependent protein kinase catalytic subunit; Ataxia telangiectasia mutated; ATM and Rad3-related kinase (DNA-PKcs; ATM; ATR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-dependent protein kinase catalytic subunit; Ataxia telangiectasia mutated; ATM and Rad3-related kinase (DNA-PKcs; ATM; ATR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call